Results 251 to 260 of about 3,272,245 (333)
ABSTRACT Background The aim of this study was to determine the prevalence of Helicobacter pylori in relation to endoscopic and histopathology features and to find out the correlation between the two diagnostic methods. Methods Gastroduodenal biopsy specimens were collected from 475 dyspeptic outpatients who attended the Department of Gastroenterology ...
Laure Brigitte Kouitcheu Mabeku+7 more
wiley +1 more source
Editorial: Clinical management of Helicobacter pylori infections
Raffaele Pellegrino+2 more
doaj +1 more source
Association of <i>Helicobacter pylori</i> with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis. [PDF]
Ergün S+6 more
europepmc +1 more source
Managing <i>Helicobacter pylori</i>: elimination challenges. [PDF]
Rahimi F, Talebi Bezmin Abadi A.
europepmc +1 more source
Genetically identical bacteria in the same environment sometimes behave differently. This happens for the expression of wbpL, a gene of plant pathogenic Pseudomonas syringae that shapes the bacterial surface and is important for infection and immunity.
Laura Mancera‐Miranda+4 more
wiley +1 more source
Prevalence and Variability of <i>Helicobacter pylori</i> Clarithromycin Resistance Mutations in Pediatric Patients in Poland: A Genotypic Analysis Using the Bosphore Genotyping Kit. [PDF]
Bogiel T+2 more
europepmc +1 more source
Microbiota–Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases
Bacterial dysbiosis results from microbiota imbalances, diet, lifestyle, and other factors that lead to conditions such as IBS, IBD, acne, dermatitis, and dental diseases. The current therapeutic approaches include probiotics, prebiotics, synbiotics, microbiota transplantation, and phage therapy.
Siau Wui Chin+3 more
wiley +1 more source
Characteristics of gastric fluid microbiota in patients with refractory <i>Helicobacter pylori</i> infection. [PDF]
Zhu H+5 more
europepmc +1 more source
This review discussed the signaling pathways of Toll‐like receptors in tumors and their antitumor or protumor regulatory effects in diverse tumors. We also paid attention to the application of Toll‐like receptors in clinical treatment and summarized the clinical trial situation in recent years.
Nueraili Maihemuti+7 more
wiley +1 more source